Cargando…

The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism

STUDY OBJECTIVE: The primary aim of this study was to investigate whether IMA levels are helpful in the diagnosis of pulmonary embolism (PE). The secondary aim was to determine whether IMA was more effective alone or in combination with clinical probability scores in the diagnosis of PE. Thirdly, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Turedi, Suleyman, Gunduz, Abdulkadir, Mentese, Ahmet, Topbas, Murat, Karahan, Suleyman C, Yeniocak, Selman, Turan, Ibrahim, Eroglu, Oguz, Ucar, Utku, Karaca, Yunus, Turkmen, Suha, Russell, Robert M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430960/
https://www.ncbi.nlm.nih.gov/pubmed/18513410
http://dx.doi.org/10.1186/1465-9921-9-49
_version_ 1782156434065063936
author Turedi, Suleyman
Gunduz, Abdulkadir
Mentese, Ahmet
Topbas, Murat
Karahan, Suleyman C
Yeniocak, Selman
Turan, Ibrahim
Eroglu, Oguz
Ucar, Utku
Karaca, Yunus
Turkmen, Suha
Russell, Robert M
author_facet Turedi, Suleyman
Gunduz, Abdulkadir
Mentese, Ahmet
Topbas, Murat
Karahan, Suleyman C
Yeniocak, Selman
Turan, Ibrahim
Eroglu, Oguz
Ucar, Utku
Karaca, Yunus
Turkmen, Suha
Russell, Robert M
author_sort Turedi, Suleyman
collection PubMed
description STUDY OBJECTIVE: The primary aim of this study was to investigate whether IMA levels are helpful in the diagnosis of pulmonary embolism (PE). The secondary aim was to determine whether IMA was more effective alone or in combination with clinical probability scores in the diagnosis of PE. Thirdly, the sensitivity and specificity of IMA is compared with D-dimer both with and without clinical probability scores in patients with suspected PE. METHODS: Consecutive patients presenting to the emergency department with suspected PE were prospectively recruited, and healthy volunteers were also enrolled as controls. D-dimer and IMA levels were measured for the entire study group. Wells and Geneva scores were calculated and s-CTPA was performed on all suspected PE patients. RESULTS: The study population consisted of 130 patients with suspected PE and 59 healthy controls. Mean IMA levels were 0.362 ± 0.11 ABSU for Group A, the PE group (n = 75); 0.265 ± 0.07 ABSU for Group B, the non-PE group (n = 55); and 0.175 ± 0.05 ABSU for Group C, the healthy control group (p < 0.0001). At a cut-off point of 0.25 ABSU, IMA was 93% sensitive and 75% specific in the diagnosis of PE. PPV was 79.4% and NPV was 78.6%. Mean D-dimer levels were 12.48 ± 10.88 μg/ml for Group A; 5.36 ± 7.80 μg/ml for Group B and 0.36 ± 0.16 μg/ml for Group C (p < 0.0001). The D-dimer cut-off point was 0.81 μg/ml with a sensitivity of 98.9% and a specificity of 62.7%, PPV of 69.4% and NPV of 83.3%. The use of IMA in combination with Wells and Geneva clinical probability scores was determined to have a positive impact on these scores' sensitivity and negative predictive values. CONCLUSION: IMA is a good alternative to D-dimer in PE diagnosis in terms of both cost and efficiency. Used in combination with clinical probability scores, it has a similar positive effect on NPV and sensitivity to that of D-dimer. The PPV of IMA is better than D-dimer, but it is still unable to confirm a diagnosis of PE without additional investigation.
format Text
id pubmed-2430960
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-24309602008-06-19 The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism Turedi, Suleyman Gunduz, Abdulkadir Mentese, Ahmet Topbas, Murat Karahan, Suleyman C Yeniocak, Selman Turan, Ibrahim Eroglu, Oguz Ucar, Utku Karaca, Yunus Turkmen, Suha Russell, Robert M Respir Res Research STUDY OBJECTIVE: The primary aim of this study was to investigate whether IMA levels are helpful in the diagnosis of pulmonary embolism (PE). The secondary aim was to determine whether IMA was more effective alone or in combination with clinical probability scores in the diagnosis of PE. Thirdly, the sensitivity and specificity of IMA is compared with D-dimer both with and without clinical probability scores in patients with suspected PE. METHODS: Consecutive patients presenting to the emergency department with suspected PE were prospectively recruited, and healthy volunteers were also enrolled as controls. D-dimer and IMA levels were measured for the entire study group. Wells and Geneva scores were calculated and s-CTPA was performed on all suspected PE patients. RESULTS: The study population consisted of 130 patients with suspected PE and 59 healthy controls. Mean IMA levels were 0.362 ± 0.11 ABSU for Group A, the PE group (n = 75); 0.265 ± 0.07 ABSU for Group B, the non-PE group (n = 55); and 0.175 ± 0.05 ABSU for Group C, the healthy control group (p < 0.0001). At a cut-off point of 0.25 ABSU, IMA was 93% sensitive and 75% specific in the diagnosis of PE. PPV was 79.4% and NPV was 78.6%. Mean D-dimer levels were 12.48 ± 10.88 μg/ml for Group A; 5.36 ± 7.80 μg/ml for Group B and 0.36 ± 0.16 μg/ml for Group C (p < 0.0001). The D-dimer cut-off point was 0.81 μg/ml with a sensitivity of 98.9% and a specificity of 62.7%, PPV of 69.4% and NPV of 83.3%. The use of IMA in combination with Wells and Geneva clinical probability scores was determined to have a positive impact on these scores' sensitivity and negative predictive values. CONCLUSION: IMA is a good alternative to D-dimer in PE diagnosis in terms of both cost and efficiency. Used in combination with clinical probability scores, it has a similar positive effect on NPV and sensitivity to that of D-dimer. The PPV of IMA is better than D-dimer, but it is still unable to confirm a diagnosis of PE without additional investigation. BioMed Central 2008 2008-05-30 /pmc/articles/PMC2430960/ /pubmed/18513410 http://dx.doi.org/10.1186/1465-9921-9-49 Text en Copyright © 2008 Turedi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Turedi, Suleyman
Gunduz, Abdulkadir
Mentese, Ahmet
Topbas, Murat
Karahan, Suleyman C
Yeniocak, Selman
Turan, Ibrahim
Eroglu, Oguz
Ucar, Utku
Karaca, Yunus
Turkmen, Suha
Russell, Robert M
The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism
title The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism
title_full The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism
title_fullStr The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism
title_full_unstemmed The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism
title_short The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism
title_sort value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430960/
https://www.ncbi.nlm.nih.gov/pubmed/18513410
http://dx.doi.org/10.1186/1465-9921-9-49
work_keys_str_mv AT turedisuleyman thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT gunduzabdulkadir thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT menteseahmet thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT topbasmurat thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT karahansuleymanc thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT yeniocakselman thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT turanibrahim thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT erogluoguz thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT ucarutku thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT karacayunus thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT turkmensuha thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT russellrobertm thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT turedisuleyman valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT gunduzabdulkadir valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT menteseahmet valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT topbasmurat valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT karahansuleymanc valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT yeniocakselman valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT turanibrahim valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT erogluoguz valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT ucarutku valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT karacayunus valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT turkmensuha valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism
AT russellrobertm valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism